Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adverse effects of clinical intervention on the complement system.

S E Svehag1

  • 1Department of Medical Microbiology, Odense University, Denmark.

Complement and Inflammation
|January 1, 1991
PubMed
Summary

Adverse effects from blood processing and certain drugs can activate the complement (C) system. Understanding C activation mechanisms is key to preventing these reactions during medical treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies.

Antiviral research·2001
Same author

ELISA for evaluating the incorporation of plasma derived complement split-products C3b/iC3b into solid-phase immune complexes.

Journal of immunological methods·2001
Same author

Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients.

Journal of clinical immunology·2001
Same author

Localization of human serum amyloid P component and heparan sulfate proteoglycan in in vitro-formed Abeta fibrils.

Scandinavian journal of immunology·2000
Same author

Complement activation by the amyloid proteins A beta peptide and beta 2-microglobulin.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·1999
Same author

Electron microscopy of prefibrillar structures and amyloid fibrils.

Methods in enzymology·1999

Area of Science:

  • Biochemistry
  • Immunology
  • Medical Device Technology

Background:

  • Extracorporeal blood processing, including hemodialysis and bypass oxygenation, can activate the complement (C) system.
  • Activation of the alternative C pathway can lead to adverse reactions during extracorporeal circuits.
  • The biocompatibility of dialyzer membranes is crucial for understanding C activation.

Purpose of the Study:

  • To elucidate the mechanisms of complement (C) system activation during extracorporeal blood processing.
  • To investigate the interaction between drugs, drug metabolites, and the C system, leading to pseudoallergic reactions.
  • To understand how C activation contributes to adverse events associated with medical treatments.

Main Methods:

  • Review of studies on dialyzer membrane biocompatibility and C activation.
  • Analysis of mechanisms of drug interactions with C system regulator proteins.
  • Examination of C activation in relation to hemodialyzers, oxygenators, and plasma processing.

Main Results:

  • Extracorporeal processing via hemodialyzers, oxygenators, and plasma filtration/adsorption activates the alternative C pathway.
  • Certain drugs interfere with C system regulator proteins, potentially causing pseudoallergic reactions.
  • Long-term inhibition of C3/C4 binding may contribute to drug-induced lupus; high-dose immunoglobulins and recombinant proteins can also activate C.

Conclusions:

  • Complement (C) system activation is a common pathway for adverse effects in extracorporeal blood processing and certain drug therapies.
  • Understanding drug-C system interactions is vital for managing pseudoallergic reactions and drug-induced conditions.
  • Further research into C activation mechanisms can improve the safety of medical devices and treatments involving blood or plasma processing.

Related Experiment Videos